On September 3, 2021, TiumBio Co., Ltd. closed the transaction. The company received the final tranche from preferred stock.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,770 KRW | +1.05% |
|
-2.04% | -40.94% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,440 KRW | +0.18% | +1.96% | 105M | ||
5,090 KRW | -2.30% | -2.30% | 186M | ||
1st Jan change | Capi. | |
---|---|---|
-40.94% | 109M | |
+18.43% | 124B | |
+19.81% | 114B | |
-23.74% | 19.42B | |
-18.28% | 16.2B | |
-19.97% | 15.31B | |
-49.33% | 14.19B | |
+57.08% | 14.32B | |
+7.95% | 14.31B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- A321550 Stock
- News TiumBio Co., Ltd.
- TiumBio Co., Ltd. announced that it has received KRW 49.99982815 billion in funding from Hanyang Securities Co. Ltd., EBEST Investment & Securities Co., Ltd. and other investors